UB Paderborn / Katalog / Suche / in CDI

Anti-HER2 therapy in metastatic breast cancer: many choices and future directions

Cancer and metastasis reviews, 2022-03, Vol.41 (1), p.193-209

2022

Link zum Volltext

Verfügbarkeit prüfen

The insights of Let‐7 miRNAs in oncogenesis and stem cell potency

Journal of cellular and molecular medicine, 2016-09, Vol.20 (9), p.1779-1788

2016

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy for breast cancer: past, present, and future

Cancer and metastasis reviews, 2016-12, Vol.35 (4), p.525-546

2016

Link zum Volltext

Verfügbarkeit prüfen

MYC and DNMT3A‐mediated DNA methylation represses microRNA‐200b in triple negative breast cancer

Journal of cellular and molecular medicine, 2018-12, Vol.22 (12), p.6262-6274

2018

Link zum Volltext

Verfügbarkeit prüfen

Systemic toxicities of trastuzumab‐emtansine predict tumor response in HER2+ metastatic breast cancer

International journal of cancer, 2021-08, Vol.149 (4), p.909-916

2021

Link zum Volltext

Verfügbarkeit prüfen

The immunotherapy candidate TNFSF4 may help the induction of a promising immunological response in breast carcinomas

Scientific reports, 2021-09, Vol.11 (1), p.18587-18587, Article 18587

2021

Link zum Volltext

Verfügbarkeit prüfen

DICER1 regulated let‐7 expression levels in p53‐induced cancer repression requires cyclin D1

Journal of cellular and molecular medicine, 2015-06, Vol.19 (6), p.1357-1365

2015

Link zum Volltext

Verfügbarkeit prüfen

The race to develop oral SERDs and other novel estrogen receptor inhibitors: recent clinical trial results and impact on treatment options

Cancer and metastasis reviews, 2022-12, Vol.41 (4), p.975-990

2022

Link zum Volltext

Verfügbarkeit prüfen

Stem signatures associating SOX2 antibody helps to define diagnosis and prognosis prediction with esophageal cancer

Annals of medicine (Helsinki), 2022-12, Vol.54 (1), p.921-932

2022

Link zum Volltext

Verfügbarkeit prüfen

LINC00891 regulated by miR-128-3p/GATA2 axis impedes lung cancer cell proliferation, invasion and EMT by inhibiting RhoA pathway

Acta biochimica et biophysica Sinica, 2022-03, Vol.54 (3), p.378-387

2022

Link zum Volltext

Verfügbarkeit prüfen

M6A associated TSUC7 inhibition contributed to Erlotinib resistance in lung adenocarcinoma through a notch signaling activation dependent way

Journal of experimental & clinical cancer research, 2021-10, Vol.40 (1), p.325-325, Article 325

2021

Link zum Volltext

Verfügbarkeit prüfen

Targeting EGFR/HER2/HER3 with a Three-in-One Aptamer-siRNA Chimera Confers Superior Activity against HER2+ Breast Cancer

Molecular therapy. Nucleic acids, 2018-03, Vol.10, p.317-330

2018

Link zum Volltext

Verfügbarkeit prüfen

Breast cancer stem-like cells are sensitized to tamoxifen induction of self-renewal inhibition with enforced Let-7c dependent on Wnt blocking

International journal of molecular medicine, 2018-04, Vol.41 (4), p.1967-1975

2018

Link zum Volltext

Verfügbarkeit prüfen

Enhancement of TKI sensitivity in lung adenocarcinoma through m6A-dependent translational repression of Wnt signaling by circ-FBXW7

Molecular cancer, 2023-07, Vol.22 (1), p.103-103, Article 103

2023

Link zum Volltext

Verfügbarkeit prüfen

Stem signatures associated antibodies yield early diagnosis and precise prognosis predication of patients with non-small cell lung cancer

Journal of cancer research and clinical oncology, 2021, Vol.147 (1), p.223-233

2021

Link zum Volltext

Verfügbarkeit prüfen

Stimulation of Let-7 Maturation by Metformin Improved the Response to Tyrosine Kinase Inhibitor Therapy in an m6A Dependent Manner

Frontiers in oncology, 2022-01, Vol.11, p.731561-731561

2022

Link zum Volltext

Verfügbarkeit prüfen

H19 regulation of oestrogen induction of symmetric division is achieved by antagonizing Let‐7c in breast cancer stem‐like cells

Cell proliferation, 2019-01, Vol.52 (1), p.e12534-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

ANG1005, a Brain-Penetrating Peptide-Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases

Clinical cancer research, 2020-06, Vol.26 (12), p.2789-2799

2020

Link zum Volltext

Verfügbarkeit prüfen

Novel taxanes in development: Hopes or hypes?

Critical reviews in oncology/hematology, 2022-08, Vol.176, p.103727-103727, Article 103727

2022

Link zum Volltext

Verfügbarkeit prüfen

Augmented expression of polo-like kinase 1 indicates poor clinical outcome for breast patients: a systematic review and meta-analysis

Oncotarget, 2017-08, Vol.8 (34), p.57723-57732

2017

Link zum Volltext

Verfügbarkeit prüfen

Expression of EGFR isoform D is regulated by HER receptor activators in breast cancer cells

Biochemistry and biophysics reports, 2022-09, Vol.31, p.101326-101326, Article 101326

2022

Link zum Volltext

Verfügbarkeit prüfen

Retrospective observational cohort study on cosmetic outcome of using Ti-Ni memory alloy wire for intradermal suture following mastectomy in patients with breast cancer

Oncology letters, 2018-02, Vol.15 (2), p.2465-2470

2018

Link zum Volltext

Verfügbarkeit prüfen

Synergistic Targeting HER2 and EGFR with Bivalent Aptamer-siRNA Chimera Efficiently Inhibits HER2-Positive Tumor Growth

Molecular pharmaceutics, 2018-11, Vol.15 (11), p.4801-4813

2018

Link zum Volltext

Verfügbarkeit prüfen

Delayed Gemcitabine-Induced Posterior Reversible Encephalopathy Syndrome

The American journal of the medical sciences, 2021-06, Vol.361 (6), p.795-798

2021

Link zum Volltext

Verfügbarkeit prüfen

TUSC7 suppression of Notch activation through sponging MiR-146 recapitulated the asymmetric cell division in lung adenocarcinoma stem cells

Life sciences (1973), 2019-09, Vol.232, p.116630-116630, Article 116630

2019

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Anti-HER2 therapy in metastatic breast cancer: many choices and future directions

The insights of Let‐7 miRNAs in oncogenesis and stem cell potency

Immunotherapy for breast cancer: past, present, and future

MYC and DNMT3A‐mediated DNA methylation represses microRNA‐200b in triple negative breast cancer

Systemic toxicities of trastuzumab‐emtansine predict tumor response in HER2+ metastatic breast cancer

The immunotherapy candidate TNFSF4 may help the induction of a promising immunological response in breast carcinomas

DICER1 regulated let‐7 expression levels in p53‐induced cancer repression requires cyclin D1

The race to develop oral SERDs and other novel estrogen receptor inhibitors: recent clinical trial results and impact on treatment options

Stem signatures associating SOX2 antibody helps to define diagnosis and prognosis prediction with esophageal cancer

LINC00891 regulated by miR-128-3p/GATA2 axis impedes lung cancer cell proliferation, invasion and EMT by inhibiting RhoA pathway

M6A associated TSUC7 inhibition contributed to Erlotinib resistance in lung adenocarcinoma through a notch signaling activation dependent way

Targeting EGFR/HER2/HER3 with a Three-in-One Aptamer-siRNA Chimera Confers Superior Activity against HER2+ Breast Cancer

Breast cancer stem-like cells are sensitized to tamoxifen induction of self-renewal inhibition with enforced Let-7c dependent on Wnt blocking

Enhancement of TKI sensitivity in lung adenocarcinoma through m6A-dependent translational repression of Wnt signaling by circ-FBXW7

Stem signatures associated antibodies yield early diagnosis and precise prognosis predication of patients with non-small cell lung cancer

Stimulation of Let-7 Maturation by Metformin Improved the Response to Tyrosine Kinase Inhibitor Therapy in an m6A Dependent Manner

H19 regulation of oestrogen induction of symmetric division is achieved by antagonizing Let‐7c in breast cancer stem‐like cells

ANG1005, a Brain-Penetrating Peptide-Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases

Novel taxanes in development: Hopes or hypes?

Augmented expression of polo-like kinase 1 indicates poor clinical outcome for breast patients: a systematic review and meta-analysis

Expression of EGFR isoform D is regulated by HER receptor activators in breast cancer cells

Retrospective observational cohort study on cosmetic outcome of using Ti-Ni memory alloy wire for intradermal suture following mastectomy in patients with breast cancer

Synergistic Targeting HER2 and EGFR with Bivalent Aptamer-siRNA Chimera Efficiently Inhibits HER2-Positive Tumor Growth

Delayed Gemcitabine-Induced Posterior Reversible Encephalopathy Syndrome

TUSC7 suppression of Notch activation through sponging MiR-146 recapitulated the asymmetric cell division in lung adenocarcinoma stem cells

Suchergebnisse filtern